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In a recent issue of Cancer Letters Gouveia and colleagues [1] studied a series of 40 Angolan 
patients diagnosed with Urogenital Schistosomiasis (UGS). They reported that 45% of them 
presented UGS-associated Squamous Cell Carcinoma (SCC) and/or urothelial cell carcinoma [1]. 
In addition these authors performed Liquid Chromatography-Mass Spectrometry and this analysis 
revealed numerous estrogens like metabolites. These schistosome infection-associated metabolites 
included Catechol Estrogen Quinones (CEQ) and CEQ-DNA-adducts, two of which had been 
identified previously in S. haematobium [1-3]. They conclude suggesting that these metabolites can 
be expected to provide deeper insights into the carcinogenesis UGS-induced bladder cancer, and as 
biomarkers for diagnosis and/or prognosis of this neglected tropical disease-linked cancer.
The results we have recently obtained partly confirm and partly diverge from the results 
reported by Gouveia and colleagues [1]. We have studied 300 individuals from the North of Angola 
[4]. Prevalence of S. haematobium infection was 71.7% (215/300). Ultrasound and cystoscopy 
examinations revealed pathological conditions at the urinary tract in all examined in a sub-sample 
of 29 (13.5%) of the patients diagnosed with UGS. One case (0.3%) presented with a vesical tumor. 
This tumor was classified as Squamous Cell Carcinoma (SCC) [4]. The low frequency of tumors 
found in our series in comparison to the high frequencies of tumors in the series of Gouveia, et al. 
[1] suggests that bladder cancer associated to UGS might have an increased burden than already 
described previously. In fact other authors reported that the incidence of SCC is 3-4/100000 cases 
[5] which are more in agreement with our study. 
In keeping with the results of Gouveia and colleagues [1] we have previously described 
estrogen metabolites to be associated with schistosomiasis infected persons [6-8]. Our group has 
been working on the identification of parasite derived compounds that might be implicated in the 
carcinogenesis of S. haematobium. The majority of these compounds are catechol estrogens. The 
carcinogenic effect of this estrogen–DNA adduct mediated pathway could explain the link between 
chronic schistosomiasis haematobia and SCC of the bladder [6-8]. The association found by Gouveia 
and colleagues [1] and our selves between estrogen metabolites and schistosomiasis associated 
bladder cancer remains to be clarified.
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